BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Replikins: New Finding of Rise in H5N1 Virus (Avian Flu) Replikin Count


10/28/2010 7:00:48 AM

BOSTON, Oct. 27 /PRNewswire/ -- BioRadar software correctly predicted the 2009 H1N1 (Swine Flu) outbreak a year in advance (http://www.replikins.com, Replikins Press, 2008). The same rise in Replikin Count of these genomic Replikin genes, this time in the H5N1 (Bird Flu) virus, may similarly warn of the coming of severe outbreaks in H5N1.

Specifically, BioRadar analyzed two separate Replikins* genes, one for infectivity and one for lethality. The high H5N1 lethality gene Replikin Count, rising since 2006 (6.0+/-7.0), has continued to rise to a high in 2010 (9.1+/-8.5) (p<0.001). BioRadar predicted in 2009 an increase in H5N1 outbreaks and more outbreaks appeared in 16 countries by mid-2010. The previous low infectivity of H5N1, correlated with a low Replikin Count, has been reassuring. The finding in 2010 of a significant increase in the Replikin Count of the H5N1 infectivity gene as well, in "scout" viruses to 8.4, its highest level in 53 years, is of concern.

By means of BioRadar software, Replikins were identified in all sequences (N, H5N1=25,358) from PubMed and from Global BioRadar Surveillance System participants.

The studies were conducted by Samuel Bogoch, M.D., Ph.D. and Elenore S. Bogoch, M.D., Boston University School of Medicine and BioRadar UK, Ltd.

*About Replikins

Replikins are a new group of genomic peptide structures in viruses, other infectious disease agents, and cancer cells, which are associated with rapid replication (http://www.replikins.com). Two genes have been isolated in silico in viruses and relate to infectivity and lethality respectively. The increase in Replikin concentration (Replikin Count=Number of Replikins per 100 amino acids) in the virus Infectivity Gene precedes an increase in clinical infectivity and spread; and an increase in the virus Lethality Gene precedes an increase in lethality clinically.

Contact: Dr. Sam Bogoch, 617-536-9711

This press release was issued through eReleases(R). For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.

SOURCE Replikins Ltd.



Read at BioSpace.com

Replikins
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES